Table 2.
Demographic and clinical characteristics in 38 Italian patients with fibromyalgia syndrome treated with medical cannabis
| Parameter | N = 38 | |||
|---|---|---|---|---|
| Gender, female: male | 36:2 | |||
| Mean | ± SD | Median | IQR | |
| Age, years | 56.6 | 9.8 | 56 | 10.75 |
| Months between diagnosis of FMS and prescription of MC | 91.1 | 73.5 | 78 | 84 |
| Body mass index (Kg/m2) | 25.8 | 5.8 | 24 | 5.5 |
| Numerical Rating Scale | 8.2 | 1.4 | 8 | 1.5 |
| Oswestry disability index | 55.5 | 17.6 | 55 | 29.5 |
| HADS anxiety | 12 | 4.5 | 11.5 | 8 |
| HADS depression | 11.7 | 4.6 | 12.5 | 7.25 |
| Widespread Pain Index | 14.4 | 4.1 | 15 | 7 |
| SyS | 10.1 | 1.4 | 10.5 | 1.5 |
N number of patients, ± plus/minus, SD standard deviation, IQR interquartile range, FMS fibromyalgia syndrome, MC medical cannabis, HADS Hospital Anxiety and Depression Scale, Sys severity score